|
C3a (72-77) (human)
|
HIS-LEU-GLY-LEU-ALA-ARG
|
|
|
Platelet Membrane Glycoprotein IIB Peptide (296-306)
|
GLYCOPROTEIN IIB FRAGMENT (296-306)
|
|
|
GAD65 (206-220)
|
THR-TYR-GLU-ILE-ALA-PRO-VAL-PHE-VAL-LEU-LEU-GLU-TYR-VAL-THR
|
|
|
Hsp Heat shock protein (3-13)
|
LYS-THR-ILE-ALA-TYR-ASP-GLU-GLU-ALA-ARG-ARG
|
|
|
HPV-E6-N
|
ASP-PRO-GLN-GLU-ARG-PRO-ARG-LYS-LEU-PRO-GLN-LEU-CYS-THR-GLU
|
|
|
FDC-SP (61-85), human
|
PHE-PRO-TRP-PHE-ARG-ARG-ASN-PHE-PRO-ILE-PRO-ILE-PRO-GLU-SER-ALA-PRO-THR-THR-PRO-LEU-PRO-SER-GLU-LYS
|
|
|
Experimental Autoimmune Encephalomyelitis Complementary Peptide
|
VAL-PHE-ILE-LEU-GLY-PRO-LEU-ARG-LEU-LEU-GLY
|
|
|
G250.A2
|
HIS-LEU-SER-THR-ALA-PHE-ALA-ARG-VAL
|
|
|
Head activator (7-11)
|
HEAD ACTIVATOR (7-11)
|
|
|
HPV-E7-N
|
TYR-MET-LEU-ASP-LEU-GLN-PRO-GLU-THR-THR-ASP-LEU-TYR-CYS-TYR-GLU-GLN-LEU-ASN-ASP
|
|
|
F1 Peptide,lobster
|
THR-ASN-ARG-ASN-PHE-LEU-ARG-PHE-NH2
|
|
|
Gluten Exorphin A5
|
GLY-TYR-TYR-PRO-THR
|
|
|
Rcramp
|
GLY-LEU-VAL-ARG-LYS-GLY-GLY-GLU-LYS-PHE-GLY-GLU-LYS-LEU-ARG-LYS-ILE-GLY-GLN-LYS-ILE-LYS-GLU-PHE-PHE-GLN-LYS-LEU-ALA-LEU-GLU-ILE-GLU-GLN
|
|
|
Rigin
|
GLY-GLN-PRO-ARG
|
77727-17-4
|
|
ERKtide
|
ALA-THR-GLY-PRO-LEU-SER-PRO-GLY-PRO-PHE-GLY-ARG-ARG
|
|
|
Hemoglobin (Hb) (64-76)
|
GLY-LYS-LYS-VAL-ILE-THR-ALA-PHE-ASN-GLU-GLY-LEU-LYS
|
|
|
Glycogen Synthase-derived peptide
|
LYS-LYS-LEU-ASN-ARG-THR-LEU-SER-VAL-ALA
|
|
|
Locustachykinin I
|
GLY-PRO-SER-GLY-PHE-TYR-GLY-VAL-ARG-NH2
|
|
|
Glycoprotein Hormone a (32-46) amide
|
CYS-PHE-SER-ARG-ALA-TYR-PRO-THR-PRO-LEU-ARG-SER-LYS-LYS-THR-NH2
|
|
|
G-P-R
|
GLY-PRO-ARG
|
|
|
HER2/neu (869-877)
|
LEU-LEU-ASP-ILE-ASP-GLU-THR-GLU-TYR
|
|
|
RES-701-3
|
GLY-ASN-TRP-HIS-GLY-THR-SER-PRO-ASP-TRP-PHE-PHE-ASN-TYR-TYR-TRP
|
|
|
Hemorphin-7
|
TYR-PRO-TRP-THR-GLN-ARG-PHE
|
|
|
GAD65 (78–97)
|
LYS-PRO-CYS-ASN-CYS-PRO-LYS-GLY-ASP-VAL-ASN-TYR-ALA-PHE-LEU-HIS-ALA-THR-ASP-LEU
|
|
|
Morphine Modulating Peptide, C-Terminal Fragment
|
H-PRO-GLN-ARG-PHE-NH2
|
|
|
FDC-SP (30-85), human
|
SER-ILE-SER-ASP-SER-ASP-GLU-LEU-ALA-SER-GLY-PHE-PHE-VAL-PHE-PRO-TYR-PRO-TYR-PRO-PHE-ARG-PRO-LEU-PRO-PRO-ILE-PRO-PHE-PRO-ARG-PHE-PRO-TRP-PHE-ARG-ARG-ASN-PHE-PRO-ILE-PRO-ILE-PRO-GLU-SER-ALA-PRO-THR-THR-PRO-LEU-PRO-SER-GLU-LYS
|
|
|
Head activator
|
GLP-PRO-PRO-GLY-GLY-SER-LYS-VAL-ILE-LEU-PHE
|
|
|
HPV-E6-C
|
PRO-LEU-CYS-PRO-GLU-GLU-LYS-GLN-ARG-HIS-LEU-ASP-LYS-LYS-GLN-ARG-PHE-HIS-ASN-ILE
|
|
|
Necrofibrin, human
|
GLY-ALA-VAL-SER-THR-ALA
|
|
|
Erythromycin resistance peptide
|
MET-ARG-LEU-PHE-VAL
|
|
|
GnT-V (nt38-67)
|
VAL-LEU-PRO-ASP-VAL-PHE-ILE-ARG-CYS-VAL
|
|
|
Cathepsin G (77-83)
|
HIS-PRO-GLN-TYR-ASN-GLN-ARG
|
|
|
Pressinoic Acid
|
CYS-TYR-PHE-GLN-ASN-CYS(DISULFIDE BRIDGE CYS1-CYS6)
|
|
|
Cripto-1, CR-1
|
CYS-PRO-PRO-SER-PHE-TYR-GLY-ARG-ASN-CYS-GLU-HIS-ASP-VAL-ARG-LYS-GLU
|
|
|
Biotin-LC-Neurogranin (28-43)
|
BIOTIN-LC-ALA-ALA-LYS-ILE-GLN-ALA-SER-PHE-ARG-GLY-HIS-MET-ALA-ARG-LYS-LYS
|
|
|
EMP-1 (Epithelial Membrane Protein)
|
GLY-GLY-THR-TYR-SER-CYS-HIS-PHE-GLY-PRO-LEU-THR-TRP-VAL-CYS-LYS-PRO-GLN-GLY-GLY
|
|
|
CB-TH
|
ARG-TRP-LYS-ILE-PHE-LYS-LYS-ILE-GLU-LYS-MET-GLY-GLY-SER-TYR-CYS-ASN-ARG-ARG-THR-GLY-LYS-CYS-GLN-ARG-MET
|
|
|
Dok-5 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-GLN-HIS-ILE-THR-ARG-GLN
|
|
|
Dok-6 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-HIS-HIS-ILE-THR-ARG-GLN
|
|
|
DAP10 Signaling Fragment
|
PRO-ALA-GLN-GLU-ASP-GLY-LYS-VAL-TYR-ILE-ASN-MET-PRO-GLY-ARG-GLY
|
|
|
CDR-H3/C2
|
CYS-ASP-LEU-ILE-TYR-TYR-ASP-TYR-GLU-GLU-ASP-TYR-TYR-PHE-ASP-CYS (DISULFIDE BRIDGE: CYS1-CYS16)
|
|
|
Endonuclease Antigenic Site
|
GLU-THR-GLY-GLN-GLU-THR-ALA-TYR-PHE-LEU-LEU-LYS-LEU-ALA-GLY-ARG-TRP-PRO-VAL-LYS
|
|
|
Dermorphin Analog
|
TYR-D-ARG-PHE-SAR-TYR-PRO-SER-NH2
|
|
|
CK1tide
|
HIS-ALA-ALA-ILE-GLY-ASP-ASP-ASP-ASP-ALA-TYR-SER-ILE-THR-SER-NH2
|
|
|
I-309 (human)
|
LYS-SER-MET-GLN-VAL-PRO-PHE-SER-ARG-CYS-CYS-PHE-SER-PHE-ALA-GLU-GLN-GLU-ILE-PRO-LEU-ARG-ALA-ILE-LEU-CYS-TYR-ARG-ASN-THR-SER-SER-ILE-CYS-SER-ASN-GLU-GLY-LEU-ILE-PHE-LYS-LEU-LYS-ARG-GLY-LYS-GLU-ALA-CYS-ALA-LEU-ASP-THR-VAL-GLY-TRP-VAL-GLN-ARG-HIS-ARG-LYS-MET
|
|
|
Human Papillomavirus E7 protein (49 - 57)
|
ARG-ALA-HIS-TYR-ASN-ILE-VAL-THR-PHE
|
|
|
Conantokin T, Marine snail, Conus tullpa
|
GLY-GLU-GLA-GLA-TYR-GLN-LYS-MET-LEU-GLA-ASN-LEU-ARG-GLA-ALA-GLU-VAL-LYS-LYS-ASN-ALA-NH2
|
|
|
Ep-CAM (263-271)
|
GLY-LEU-LYS-ALA-GLY-VAL-ILE-ALA-VAL
|
|
|
Brevinin-1
|
BREVININ-1
|
|
|
Biotin-Intermedin (rat)
|
BIOTIN-PRO-HIS-ALA-GLN-LEU-LEU-ARG-VAL-GLY-CYS-VAL-LEU-GLY-THR-CYS-GLN-VAL-GLN-ASN-LEU-SER-HIS-ARG-LEU-TRP-GLN-LEU-VAL-ARG-PRO-SER-GLY-ARG-ARG-ASP-SER-ALA-PRO-VAL-ASP-PRO-SER-SER-PRO-HIS-SER-TYR-NH2
|
|
|
CLIP(85-99)
|
LYS-PRO-VAL-SER-GLN-MET-ARG-MET-ALA-THR-PRO-LEU-LEU-MET-ARG
|
|
|
Doc-6 (130-145)
|
GLY-VAL-GLN-ARG-GLU-GLN-ASN-GLU-ARG-PHE-ASN-VAL-TYR-LEU-MET-PRO
|
|
|
E75, Her-2/neu (369-377)
|
LYS-ILE-PHE-GLY-SER-LEU-ALA-PHE-LEU
|
|
|
CDPKS,Syntide analog
|
PRO-LEU-ARG-ARG-THR-LEU-SER-VAL-ALA-ALA
|
|
|
Dok-4 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-HIS-HIS-ILE-THR-GLY-SER
|
|
|
Delta (Phospho) Sleep Inducing Peptide
|
TRP-ALA-GLY-GLY-ASP-ALA-SER(PO3H2)-GLY-GLU
|
|
|
Dok-4 (130-145)
|
GLY-VAL-GLN-CYS-GLU-GLN-THR-ASP-ARG-PHE-ASN-VAL-PHE-LEU-LEU-PRO
|
|
|
Forkhead derived peptide, Woodtide
|
LYS-LYS-ILE-SER-GLY-ARG-LEU-SER-PRO-ILE-MET-THR-GLU-GLN-NH2
|
|
|
HPV-E6-M
|
SER-GLU-TYR-PRO-HIS-TYR-CYS-TYR-SER-LEU-TYR-GLY-THR-THR-LEU-GLU-GLN-GLN-TYR-ASN
|
|
|
K-R-Q-H-P-G
|
LYS-ARG-GLN-HIS-PRO-GLY
|
|
|
NubO (68-75), Ndufa4 (68-75)
|
VAL-ASN-VAL-ASP-TYR-SER-LYS-LEU
|
|
|
NPF
|
LYS-ARG-SER-TYR(PO3H2)-GLU-GLU-HIS-ILE-PRO
|
|
|
MSP-1 P2, Malaria Merozoite Surface Peptide – 1
|
GLY-TYR-ARG-LYS-PRO-LEU-ASP-ASN-ILE-LYS-ASP-ASN-VAL-GLY-LYS-MET-GLU-ASP-TYR-ILE-LYS-LYS
|
|
|
P61 (343-355), M. leprae
|
ARG-VAL-ALA-GLN-ILE-ARG-THR-GLU-ILE-GLU-ASN-SER-ASP
|
|
|
Murine CMV pp 89 (170-174)
|
HIS-PHE-MET-PRO-THR
|
|
|
Kemptide Negative Control
|
LEU-ARG-ARG-ALA-ALA-LEU-GLY
|
|
|
Neo-Kyotorphin
|
NEO-KYOTORPHIN
|
|
|
Leucomyosuppressin (lms)
|
PYR-ASP-VAL-ASP-HIS-VAL-PHE-LEU-ARG-PHE-NH2
|
|
|
PAKtide
|
ARG-ARG-ARG-LEU-SER-PHE-ALA-GLU-PRO-GLY
|
|
|
NES Topoisomerase II alpha (1017-1028)
|
ASP-ILE-LEU-ARG-ASP-PHE-PHE-GLU-LEU-ARG-LEU-LYS
|
|
|
Myristoylated ADP-Ribosylation Factor 1, myr-ARF1 (2-17)
|
MYRISTOYL -GLY-ASN-ILE-PHE-ALA-ASN-LEU-PHE-LYS-GLY-LEU-PHE-GLY-LYS-LYS-GLU
|
|
|
Myristoylated ADP-Ribosylation Factor 6, myr-ARF6 (2-13)
|
MYRISTOYL -GLY-LYS-VAL-LEU-SER-LYS-ILE-PHE-GLY-ASN-LYS-GLU
|
|
|
p3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54–68)
|
PHE-GLU-ALA-LYS-GLY-ALA-LYS-ALA-ASN-LYS-ALA-VAL-ASP
|
|
|
KL-1
|
LEU-PRO-PRO-VAL-ALA-ALA-SER-SER-LEU-ARG-ASN-ASP
|
|
|
P38 (411-425), M. leprae
|
ALA-GLY-GLY-GLY-VAL-THR-LEU-LEU-GLN-ALA-ALA-PRO-ALA-LEU-ASP
|
|
|
IP3R-derived Peptide
|
GLY-ARG-ARG-GLU-SER-LEU-THR-SER-PHE-GLY-NH2
|
|
|
Lytic Peptide, SB-37
|
LYTIC PEPTIDE SHIVA-1
|
|
|
LMP2 (236-244) , RRR
|
ARG-ARG-ARG-TRP-ARG-ARG-LEU-THR-VAL
|
|
|
LMP1 (156-164),IAL
|
ILE-ALA-LEU-TYR-LEU-GLN-GLN-ASN-TRP
|
|
|
NPV
|
棉铃虫核多角体病毒
|
|
|
LMP1,TDD
|
THR-ASP-ASP-SER-GLY-HIS-GLU-SER-ASP-SER-ASN-SER-ASN-GLU-GLY-ARG-HIS
|
|
|
Nuclear Export Signal, NES, PKI
|
GLU-LEU-ALA-LEU-LYS-LEU-ALA-GLY-LEU-ASP-ILE-ASN
|
|
|
N-10 Region of TRAP
|
ASP-GLU-ILE-LYS-TYR-SER-GLU-GLU-VAL-CYS
|
|
|
MSP-1 (20-39), Merozoite Surface Peptide 1
|
VAL-THR-HIS-GLU-SER-TYR-GLN-GLU-LEU-VAL-LYS-LYS-LEU-GLU-ALA-LEU-GLU-ASP-ALA-VAL
|
|
|
KK4A
|
LYS-LYS-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-VAL-LEU-SER-GLY-LYS
|
|
|
Myomodulin
|
PRO-MET-SER-MET-LEU-ARG-LEU-NH2
|
|
|
OV-2, Sheep
|
LEU-ARG-ARG-ILE-ILE-ARG-LYS-ILE-ILE-HIS-ILE-ILE-LYS-LYS-NH2
|
|
|
Metamorphosin A
|
METAMORPHOSIN A
|
|
|
IRS1-derived peptide
|
LYS-LYS-SER-ARG-GLY-ASP-TYR-MET-THR-MET-GLN-ILE-GLY-NH2
|
|
|
LEAP-2 (38-77) (Human)
|
MET-THR-PRO-PHE-TRP-ARG-GLY-VAL-SER-LEU-ARG-PRO-ILE-GLY-ALA-SER-CYS-ARG-ASP-ASP-SER-GLU-CYS-ILE-THR-ARG-LEU-CYS-ARG-LYS-ARG-ARG-CYS-SER-LEU-SER-VAL-ALA-GLN-GLU
|
|
|
IELLQAR (8-branch MAPS) Selectin Binding Peptide
|
ILE-GLU-LEU-LEU-GLN-ALA-ARG
|
|
|
LKRApYLG-NH2
|
LEU-LYS-ARG-ALA-PTYR-LEU-GLY-NH2
|
|
|
Ketolide resistance Peptide MRFFV
|
H-MET-ARG-PHE-PHE-VAL-OH
|
|
|
Leucopyrokinin (LPK)
|
LEUCOPYROKININ
|
|
|
MKKp2
|
SER-LYS-GLY-LYS-SER-LYS-ARG-LYS-LYS-ASP-LEU-ARG-ILE-SER-CYS-ASN-SER-LYS
|
|
|
MARCKS Protein (159-165)
|
PHE-LYS-LYS-SER-PHE-LYS-LEU
|
|
|
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
|
MET-LEU-ALA-ARG-ARG-LYS-LYS-VAL-TYR-PRO-TYR-PRO-MET-GLU-PRO-THR-ILE-ALA-GLU-GLY-NH2
|
|
|
Invertebrate Tachykinin-I, OctTK-I
|
LYS-PRO-PRO-SER-SER-SER-GLU-PHE-ILE-GLY-LEU-MET-NH2
|
|
|
LMP2 (419-427), TYG
|
THR-TYR-GLY-PRO-VAL-PHE-MET-CYS-LEU
|
|
|
Urechistachykinin I
|
LEU-ARG-GLN-SER-GLN-PHE-VAL-GLY-SER-ARG-NH2
|
|